Sample preparation - BD MAX™ Enteric Parasite Panel - BD MAX™ Club
Feedback
Video Player is loading.
Current Time 0:00
Duration 6:21
Loaded: 2.58%
Stream Type LIVE
Remaining Time 6:21
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected
    • en (Main), selected
    June 16, 2021 - Gastrointestinal infection (GI)

    Sample preparation – BD MAX™ Enteric Parasite Panel

    Discover the basics of proper specimen preparation for the BD MAX™ Enteric Parasite Panel.
    The BD MAX™ System offers you a simplified and automated workflow with less than 1.5 minutes hands-on time per sample.

    More videos

    Why join BD MAX™ Club?

    Video Player is loading.
    Current Time 0:00
    Duration 1:20
    Loaded: 12.16%
    Stream Type LIVE
    Remaining Time 1:20
     
    1x
      • Chapters
      • descriptions off, selected
      • subtitles off, selected
      • en (Main), selected

      Connect with professionals from around the world BD MAX™ Club members represent a community of professionals in infectious diseases and molecular diagnostics. With regional meet-ups and live webinars from global experts, expand your laboratory’s network and collaborate with worldwide colleagues.

      Tailored medical and technical expertise Whether you need compelling scientific research or tutorials for troubleshooting on the BD MAX™ System, BD MAX™ Club is here to accompany your molecular diagnostics journey. Log in to your BD MAX™ Club account anywhere, anytime to access our information database.

      Exclusive members’ perks BD MAX™ Club membership unlocks doors to exclusive webinars and collaboration with industry leading experts. Engage with your colleagues in the molecular community and exchange with the BD research and development team.

      Forward Looking Statement

      The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.

      All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company’s control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.